{"DataElement":{"publicId":"7182278","version":"1","preferredName":"Subcategory for Adverse Event","preferredDefinition":"A sub-division of the AECAT values based on sponsor defined characteristics.","longName":"AE_AESCAT_SPD","context":"NRDS","contextVersion":"1","DataElementConcept":{"publicId":"6377054","version":"1","preferredName":"Adverse Event Adverse Event Subcategory","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._A subdivision of adverse event data.","longName":"2235992v1.0:6378854v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2235992","version":"1","preferredName":"Adverse Event","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-74E9-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6378854","version":"1","preferredName":"Adverse Event Subcategory","preferredDefinition":"A subdivision of adverse event data.","longName":"C83212","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event Subcategory","conceptCode":"C83212","definition":"A subdivision of adverse event data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71FC1BB0-B902-4A06-E053-F662850A84B9","latestVersionIndicator":"Yes","beginDate":"2018-07-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-27","modifiedBy":"ONEDATA","dateModified":"2018-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"71ECE5F1-945F-5464-E053-F662850A1F39","latestVersionIndicator":"Yes","beginDate":"2018-07-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-26","modifiedBy":"COOPERM","dateModified":"2021-06-08","changeDescription":"6.8.21 Released to support CDISC CDE metrics clean-up. mc 7-26-18 Created as part of the CDISC mapping task; tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7182277","version":"1","preferredName":"Adverse Event Subcategory Clinical Study Sponsor Defined Type","preferredDefinition":"A subdivision of adverse event data._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._Something distinguishable as an identifiable class based on common qualities.","longName":"AESCAT_SPD","context":"NRDS","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F55EF25-6A76-2316-E053-F662850A5C5E","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-24","modifiedBy":"ONEDATA","dateModified":"2020-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7182276","version":"1","preferredName":"Adverse Event Subcategory Clinical Study Sponsor Defined Type","preferredDefinition":"A subdivision of adverse event data.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:Something distinguishable as an identifiable class based on common qualities.","longName":"C83212:C70793:C165683:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event Subcategory","conceptCode":"C83212","definition":"A subdivision of adverse event data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F55EF25-6A4F-2316-E053-F662850A5C5E","latestVersionIndicator":"Yes","beginDate":"2020-02-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-24","modifiedBy":"ONEDATA","dateModified":"2020-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F55EF25-6A60-2316-E053-F662850A5C5E","latestVersionIndicator":"Yes","beginDate":"2020-02-24","endDate":"2022-07-12","createdBy":"TAYLORT","dateCreated":"2020-02-24","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"2/24/20 Created to support sponsor defined codelists; tmt.","administrativeNotes":"07.14.22_Released during quarterly metrics and per request from G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"7066596","version":"1","longName":"CDISC (NRDS Implementation)","context":"NRDS"},{"publicId":"7067375","version":"1","longName":"Sponsor Defined","context":"NRDS"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the subcategory of th","type":"Preferred Question Text","description":"What is the subcategory of the adverse event?","url":null,"context":"NRDS"},{"name":"CDASH Implementation Notes","type":"CDASH Implementation Note","description":"Sponsor-defined Controlled Terminology. This would most commonly be pre-printed on the CRF or screen and pre-populated in the data management system. This is not typically a question to which the site would provide an answer. AESCAT can only be used if there is an AECAT and it must be a subcategorization of AECAT.","url":null,"context":"NRDS"},{"name":"AESCAT","type":"CDASH to SDTM Mapping","description":"Maps directly to the SDTMIG variable.","url":null,"context":"NRDS"},{"name":"Case Report Form Completion Instructions","type":"CDISC CRF Instruction","description":"Record the adverse event subcategory, if not pre-printed on the CRF.","url":null,"context":"NRDS"},{"name":"CDASH Prompt","type":"Alternate Question Text","description":"[Adverse Event Subcategory]; NULL","url":null,"context":"NRDS"},{"name":"Permissible","type":"SDTM Core","description":"Permissible","url":null,"context":"NRDS"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F5891F4-49C2-6036-E053-F662850AEC13","latestVersionIndicator":"Yes","beginDate":"2020-02-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-24","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"2/24/20 tmt created for sponsor defined codelists.","administrativeNotes":"07.14.22_Released as part of the quarterly metrics and per request of G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}